Literature DB >> 20449885

Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre.

Paola Savoia1, Paolo Fava, Simona Osella-Abate, Tiziana Nardò, Alessandra Comessatti, Pietro Quaglino, Maria Grazia Bernengo.   

Abstract

Unknown melanoma occurs as metastasis to skin, nodes or viscera, without a detectable cutaneous primary tumour. We reviewed our database of 4881 melanoma patients, diagnosed and followed up prospectively for a 33-year period. We identified 93 cases of metastatic melanoma without evidence of primary; however, five of these patients had a history of a previous excision of a presumed benign lesion without histological examination and were excluded from analyses. At diagnosis, metastases were cutaneous in 35.3% of cases, nodal in 43.2% and visceral in 17% of cases; in 4.5% of patients, both skin and nodes were involved. In all cases, clinical inspection and staging procedures performed at diagnosis of metastatic disease failed to identify a primary melanoma. In 11 cases (11.8%), extensively regressed pigmented lesions (without evidence of melanoma cells at the histological examination) were documented; moreover, we identified in our series five patients with unknown primary affected by vitiligo. The 5-year and 10-year overall survival rates were 49.6 and 41.4%, respectively, with a median of 4.9 years. The 5-year and 10-year time to progression rates were 39.4 and 32.3%, respectively, with a median of 2.3 years. Survival was longer in females and showed significant differences among patients with skin, lymph node or visceral involvement at diagnosis. In melanoma patients, unknown primary represents a not so rare event, with an uncertain origin. We confirmed the relatively good prognosis of unknown primary melanoma patients, a fact that has to be taken into consideration for their management.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20449885

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  20 in total

1.  Vitiligo-like hypopigmentation and metastatic melanoma of unknown primary site: friends or foes?

Authors:  Julio Cesar Salas-Alanis; Roger Gonzalez; Giulio Fortuna
Journal:  Med Oncol       Date:  2012-12       Impact factor: 3.064

2.  Melanoma with unknown primary: report and analysis of 24 patients.

Authors:  Rita Clerico; Ugo Bottoni; Giovanni Paolino; Marina Ambrifi; Paola Corsetti; Valeria Devirgiliis; Stefano Calvieri
Journal:  Med Oncol       Date:  2012-03-30       Impact factor: 3.064

3.  Stage IV malignant melanoma of unknown primary site in a young man.

Authors:  Petros Christopoulos; Triantafyllos Doulias; Ioannis Koutelidakis; Bassileios Papaziogas
Journal:  BMJ Case Rep       Date:  2012-07-27

4.  Stage IV melanoma of unknown primary: A population-based study in the United States from 1973 to 2014.

Authors:  Jeffrey F Scott; Ruzica Z Conic; Cheryl L Thompson; Meg R Gerstenblith; Jeremy S Bordeaux
Journal:  J Am Acad Dermatol       Date:  2018-03-23       Impact factor: 11.527

5.  Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival.

Authors:  Natalie Vandeven; Christopher W Lewis; Vladimir Makarov; Nadeem Riaz; Kelly G Paulson; Daniel Hippe; Amy Bestick; Ryan Doumani; Tessa Marx; Seesha Takagishi; Timothy A Chan; Jaehyuk Choi; Paul Nghiem
Journal:  Clin Cancer Res       Date:  2017-12-15       Impact factor: 12.531

6.  Aggressive behaviour of metastatic melanoma in a patient with neurofibromatosis type 1.

Authors:  Robert W Foley; Robert M Maweni; Aurelie Fabre; David G Healy
Journal:  Case Rep Surg       Date:  2015-03-29

7.  A Solitary Melanoma Metastasis Confined to the Submandibular Gland.

Authors:  Senne Gorris; Celia Perdaens; Veerle Delvaux; Vincent Vander Poorten; Bart Neyns; Ilan Baron
Journal:  Case Rep Oncol       Date:  2021-06-18

8.  Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV.

Authors:  Bożena Cybulska-Stopa; Marta Skoczek; Marek Ziobro; Tomasz Switaj; Sławomir Falkowski; Tadeusz Morysiński; Marcin Hetnał; Ida Cedrych; Piotr Rutkowski
Journal:  Contemp Oncol (Pozn)       Date:  2013-01-04

9.  Outpatient Follow-up and Secondary Prevention for Melanoma Patients.

Authors:  Ryan G Gamble; Daniel Jensen; Andrea L Suarez; Anne H Hanson; Lauren McLaughlin; Jodi Duke; Robert P Dellavalle
Journal:  Cancers (Basel)       Date:  2010-06-07       Impact factor: 6.639

10.  Primary versus Metastatic Gastrointestinal Melanoma: A Rare Case and Review of Current Literature.

Authors:  Malorie Simons; Jason Ferreira; Rashna Meunier; Steven Moss
Journal:  Case Rep Gastrointest Med       Date:  2016-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.